Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

The rDNA debate was initiated by the molecular biologists leading the research, and within a year expanded to include the public. Fourteen key participants representing molecular biologists, ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

The global molecular cloning market size is calculated at USD 5.53 billion in 2025 and is expected to reach around USD 8.89 billion by 2034, growing at a CAGR of 5.4% for the forecasted period.Ottawa, ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

The Class 12 Biology sample paper covers topics like competition, recombinant DNA technology, immunity, and population ...